These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Steroidal Ammonium Compounds as New Neuromuscular Blocking Agents. Rao Z; Hu H; Tang J; Liu Z; Yang Y; Qiu G; Xiao Y; Liu P; Hu X; Zhou X; Hong X Chem Biol Drug Des; 2016 May; 87(5):773-83. PubMed ID: 26684806 [TBL] [Abstract][Full Text] [Related]
26. The mechanisms underlying neuromuscular block following prolonged exposure to depolarizing agents. Gissen AJ; Nastuk WL Ann N Y Acad Sci; 1966 Jan; 135(1):184-94. PubMed ID: 5221340 [No Abstract] [Full Text] [Related]
27. Interactions of methohexitone sodium and quarternary ammonium compounds at the avian neuromuscular junction [proceedings]. Elliott RC Br J Pharmacol; 1978 Jun; 63(2):393P-394P. PubMed ID: 667468 [No Abstract] [Full Text] [Related]
28. Effects of quinuronium methylsulphate on voluntary muscle. Eyre P Br J Pharmacol Chemother; 1968 Mar; 32(3):624-34. PubMed ID: 5641953 [No Abstract] [Full Text] [Related]
29. [Neuromuscular, anticholinesterase and pressor effects of quaternary ammonium compounds derived from dicresylphosphate]. Cheymol G Therapie; 1972; 27(3):543-53. PubMed ID: 4655219 [No Abstract] [Full Text] [Related]
30. NEUROMUSCULAR BLOCKING ACTIVITIES OF TWO SHORT CHAIN LINKED BIS-QUATERNARY AMMONIUM COMPOUNDS. CAVALLITO CJ; NAPOLI MD; O'DELL TB Arch Int Pharmacodyn Ther; 1964 May; 149():188-94. PubMed ID: 14169880 [No Abstract] [Full Text] [Related]
31. Effects on the spinal cord of the cat by drugs known to influence neuromuscular transmission. Domer FR; Dyas EC Br J Pharmacol Chemother; 1965 Oct; 25(2):411-7. PubMed ID: 5866721 [No Abstract] [Full Text] [Related]
32. Pharmacological investigations of some bis-quaternary ammonium salts of N,N'-bis-(aminoacylo)piperazine derivatives. I. Relationship between structure and paralyzing action. Ciborska H Arch Int Pharmacodyn Ther; 1965 Apr; 154(2):382-94. PubMed ID: 5838343 [No Abstract] [Full Text] [Related]
33. [A nondepolarizing muscle relaxant with rapidly developing and short-term action]. Danilov AF; Zhabko EP Eksp Klin Farmakol; 1998; 61(5):18-20. PubMed ID: 9854626 [TBL] [Abstract][Full Text] [Related]
35. The rate of action of competitive neuromuscular blocking agents. Waud DR J Pharmacol Exp Ther; 1967 Oct; 158(1):99-114. PubMed ID: 6054082 [No Abstract] [Full Text] [Related]
36. A re-investigation of evidence for cholinergic neuromuscular transmission in insects. Faeder IR; O'Brien RD; Salpeter MM J Exp Zool; 1970 Feb; 173(2):187-202. PubMed ID: 4314407 [No Abstract] [Full Text] [Related]
37. The influence of the cis and trans configuration of certain stilbene-derived quaternary ammonium salts on blocking of neuromuscular transmission. Zaharia CN; Schell HD Rev Roum Physiol; 1972; 9(4):371-5. PubMed ID: 4666653 [No Abstract] [Full Text] [Related]
38. CHARGE DELOCALISATION IN RELATION TO NEUROMUSCULAR BLOCKING ACTIVITY OF CERTAIN TETRA-ALKYLAMMONIUM COMPOUNDS. COLLIER B; EXLEY KA J Pharm Pharmacol; 1963 Dec; 15():SUPPL 131-3. PubMed ID: 14101597 [No Abstract] [Full Text] [Related]
39. [Myoparalytic activity of mono-quaternary ammonium derivatives of benzoic acid esters]. Kharkevich DA; Skoldinov AP; Ibadova DN Farmakol Toksikol; 1973; 36(1):44-8. PubMed ID: 4265407 [No Abstract] [Full Text] [Related]
40. The prejunctional actions of some non-depolarizing blocking drugs. Blaber LC Br J Pharmacol; 1973 Jan; 47(1):109-16. PubMed ID: 4352083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]